b-Arrestins participate in G-protein receptor signaling and act as adapter proteins that direct the recruitment, activation, and scaffolding of various cytoplasmic signaling complexes. b-Arrestin 2-deficient (Arrb2 À / À ) mice show decreased T-cell recruitment into allergic lung tissue but increased neutrophil infiltration into wounded skin. Given these opposing effects in different immune cell subsets, we investigated the role of b-arrestin 2 in the regulation of contact hypersensitivity responses. We observed significantly increased allergic ear swelling to the obligate contact sensitizers DNFB and FITC in Arrb2 À / À compared with wild-type mice. Immunohistological analyses revealed strikingly increased neutrophil infiltration with abundant subcorneal pustules in inflamed ear tissue of DNFB-allergic Arrb2 À / À mice. Experiments involving adoptive transfers of sensitized lymphocytes and bone marrow chimeric mice indicated that b-arrestin 2 exerts its anti-inflammatory effects predominantly through radioresistant, skin-resident cells in the challenge phase of contact hypersensitivity. As a potential mechanism, we found that primary cultures of b-arrestin 2-deficient keratinocytes secreted higher levels of neutrophil-attracting chemokines including CXCL1/KC in response to T cell-derived cytokines in vitro. These experimental results support a model in which b-arrestin 2 inhibits the production of proinflammatory chemokines, which limits the recruitment of myeloid immune cells and thereby attenuates allergic skin inflammation.
INTRODUCTION
G protein-coupled receptors (GPCRs) transmit environmental signals and thereby coordinate cellular responses to environmental stimuli. b-Arrestin 1 and 2 are adapter proteins that were primarily shown to terminate GPCR signaling through receptor desensitization and internalization (Zhang et al., 1997; Lefkowitz and Shenoy, 2005) . More recently, it became evident that they also act as scaffold proteins for multiple signaling molecules. For example, they link GPCR signaling to ERK1/2, Akt, and Src kinases (DeWire et al., 2007) and interact with the transcription factors NF-kB (Gao et al., 2004; Witherow et al., 2004) and STAT1 (Mo et al., 2008) . On the basis of these observations, b-arrestins have emerged as key regulators of several cell functions (Lefkowitz, 1998) including the control of GPCR-dependent chemotactic signals in immune cells during inflammatory reactions. T and B lymphocytes of b-arrestin 2-deficient animals (Arrb2 À / À ) showed impaired migration toward stimulation with stromal cell-derived factor-1a (SDF-1a/CXCL12) in vitro (Fong et al., 2002) . In an experimental model for ovalbumin-induced allergic asthma, Arrb2 À / À mice displayed reduced infiltration of inflamed lung tissue with T cells and eosinophils (Walker et al., 2003) . These findings pointed toward a positive regulatory role for b-arrestin 2 in lymphocyte chemotaxis. However, Arrb2 À / À mice also showed increased CXCL1mediated migration of neutrophils in a skin air pouch model of inflammation. Accordingly, wound excision experiments revealed elevated infiltration of neutrophils into injured skin of Arrb2 À / À mice (Su et al., 2005) . Thus, b-arrestin 2 negatively regulates neutrophil chemotaxis.
Given these opposing effects of b-arrestin 2 on different immune cell subsets, we investigated its role in experimental contact hypersensitivity (CHS), a neutrophil-rich inflammatory response in the skin that is driven by allergen-specific T lymphocytes. In this model for allergic contact dermatitis, highly reactive small molecules such as DNFB act as obligate contact sensitizers. They are called haptens because they elicit an immune response only after covalent binding to larger selfproteins. In the sensitization phase, hapten-self complexes are taken up by skin dendritic cells. Proinflammatory mediators promote dendritic cell activation and migration to the regional lymph nodes where they stimulate hapten-specific T cells (Kaplan et al., 2012) . Upon subsequent exposures of the skin to the hapten, epidermal keratinocytes alert antigen-specific effector T cells, which then secrete cytokines such as tumor necrosis factor-a (TNF-a) or IFN-g and cytotoxic molecules such as perforin or granzyme B. Damaged keratinocytes exposed to T cell-derived cytokines respond with the production of more proinflammatory cytokines and chemokines, which further promote the recruitment of myeloid immune cells, most notably neutrophils. This initially amplifies the inflammatory response but eventually contributes to repair and regeneration of the disrupted epidermal barrier function (Albanesi, 2010; Christensen and Haase, 2012; Gaffal et al., 2013) .
In our work, we found that Arrb2 À / À mice developed significantly increased CHS responses with strikingly increased neutrophil infiltration and abundant subcorneal pustules when compared with wild-type (WT) control animals. Experiments involving adoptive transfers of sensitized lymphocytes, bone marrow chimeric mice, and primary cell cultures revealed an unexpected role for b-arrestin 2 in radioresistant cells. We found that b-arrestin 2 inhibits the production of proinflammatory chemokines in cultured epidermal keratinocytes in response to T cell-derived cytokines in vitro and in T celldriven allergic skin inflammation in vivo.
RESULTS

Mice genetically deficient for b-arrestin 2 show enhanced CHS responses
In initial studies, we comparatively examined CHS responses to DNFB in Arrb2 À / À and WT C57BL/6 mice, as shown in Figure 1a . The increase in ear thickness after DNFB challenge was significantly higher in sensitized Arrb2 À / À mice compared with WT mice (Figure 1b ). CHS responses to DNFB are primarily mediated by CD8 þ cytotoxic T cells and type 1 CD4 þ T-helper cells. We therefore additionally studied CHS responses to FITC, which are mediated primarily by type 2 CD4 þ T-helper cells, as shown in Figure 1c . Again we found significantly stronger CHS responses in sensitized Arrb2 À / À when compared with WT mice (Figure 1d ). In contrast, acute ear swelling responses to the irritant 12-O-Tetradecanoylphorbol 13-acetate were similar in Arrb2 À / À and WT mice (Figure 1e and f). These results demonstrated an anti-inflammatory role for b-arrestin 2 in the regulation of contact allergic inflammation.
Enhanced CHS responses in mice lacking b-arrestin 2 are associated with increased neutrophil-rich inflammation and subcorneal pustules Histopathologic investigations of inflamed ear tissues 48 hours after the second challenge with DNFB revealed prominent tissue edema and increased numbers of infiltrating immune cells, in particular neutrophils, which often aggregated in subcorneal pustules, in sensitized Arrb2 À / À mice when compared with WT mice (Figure 2a ). Immunohistochemical analyses confirmed the infiltration with large numbers of Gr1 þ immune cells in Arrb2 À / À mice (Figure 2b ). Flow cytometric analyses revealed a predominance of Ly6C þ /G þ and CD11b þ immune cells (Figure 2b and c). Consistent with these morphologic and immunologic observations, we measured significantly increased mRNA expression levels of Il1b, S100a8, and Cxcl2, which code for proinflammatory mediators known to be secreted in large amounts by neutrophils, in inflamed ear tissue of Arrb2 À / À mice (Figure 2d ). These results pointed toward an anti-inflammatory role for b-arrestin 2 in the regulation of contact allergic skin inflammation.
b-Arrestin 2 exerts its anti-inflammatory effects predominantly in the challenge phase of CHS responses In the experimental model for ovalbumin-induced allergic asthma, Arrb2 À / À mice showed decreased numbers of T cells infiltrating inflamed lung tissue (Walker et al., 2003) . However, in DNFB-induced contact allergic dermatitis, we did not find significant differences between the number of CD3 þ T cells infiltrating inflamed skin tissue in Arrb2 À / À and WT mice (Figure 3a and b) . Interestingly, the mRNA levels of Ifng and Tnfa, two cytokines produced by hapten-specific effector T cells and innate immune cells such as NK cells and macrophages, was increased in Arrb2 À / À mice when compared with WT animals (Figure 3c ). To further investigate a potential role for b-arrestin 2 in lymphocytes during the CHS response to DNFB, we adoptively transferred bulk lymphocytes isolated from lymph nodes and spleens of sensitized Arrb2 À / À or WT mice into naïve recipient WT or Arrb2 À / À mice and determined the magnitude of allergic ear swelling upon subsequent allergen challenges ( Figure 3d ). We found that Arrb2 À / À mice that received sensitized lymphocytes from WT or Arrb2 À / À mice elicited stronger CHS responses than WT mice that received sensitized lymphocytes from WT or Arrb2 À / À mice (Figure 3e ). These results suggested that b-arrestin 2 has an important role during the challenge phase of CHS also in cells other than lymphocytes.
Radioresistant cells contribute to the anti-inflammatory activity of b-arrestin 2
On the basis of the previously published inhibitory role of b-arrestin 2 for CXCR2-mediated neutrophil recruitment in the air pouch model for skin inflammation (Su et al., 2005) , we hypothesized that b-arrestin 2 acts in myeloid immune cells such as neutrophils and macrophages by limiting their recruitment into the skin of sensitized mice upon a subsequent challenge with the contact allergen. To investigate this possibility, we generated bone marrow chimeric mice in which b-arrestin 2 was either expressed on radiosensitive immune cells or on radioresistant host cells. We irradiated two groups each of WT and Arrb2 À / À mice and reconstituted them with bone marrow derived from either WT or Arrb2 À / À mice. After 6 weeks, we sensitized and challenged these bone marrow chimeric mice with DNFB ( Figure 4a ). We observed that Arrb2 À / À mice reconstituted with bone marrow from WT mice or Arrb2 À / À mice exhibited significantly enhanced CHS responses when compared with WT mice reconstituted with bone marrow from WT mice or Arrb2 À / À mice ( Figure 4b ).
These results argued against a predominant role for b-arrestin 2 on radiosensitive immune cells including neutrophils and macrophages. Instead, they suggested that the anti-inflammatory activity of b-arrestin 2 largely resides in radioresistant cells in the skin.
b-Arrestin 2 inhibits the secretion of proinflammatory chemokines by keratinocytes
Epidermal keratinocytes are the predominant radioresistant cell type in the skin. They rapidly respond to disturbances of the epidermal barrier, including exposure to contact sensitizers, and are key players in the regulation of CHS responses (Albanesi, 2010) . By secreting proinflammatory chemokines in response to inflammatory cytokines such as TNF-a or IFN-g, which are produced by infiltrating immune cells including allergen-specific T cells, they promote the recruitment of myeloid immune cells, which help orchestrate tissue regeneration and restoration of epidermal integrity (Gaffal et al., 2013) . We therefore considered a role for b-arrestin and CXCL10. We consistently found higher levels of CCL2 and CXCL1 in the supernatants of near-confluent primary b-arrestin 2-deficient keratinocyte cultures under basal and TNF-a-induced inflammatory conditions (Figure 5a ). Following stimulation with IFN-g, we also observed increased levels of CCL8 but not of CXCL10 in b-arrestin 2-deficient keratinocytes ( Figure 5b ). Consistent with our in vitro findings, we detected significantly increased mRNA expression levels of Ccl2, Cxcl1, and Ccl8 in contact allergic ear tissue of Arrb2 À / À when compared with WT mice (Figure 5c ). From these results, we concluded that b-arrestin 2 in epidermal keratinocytes inhibits the production of proinflammatory chemokines particularly in response to TNF-a and IFN-g, two cytokines secreted by allergen-specific T cells.
DISCUSSION
In this study, we investigated the role of b-arrestin 2 for the regulation of allergic inflammation in the experimental mouse model of CHS. We found that mice genetically deficient for the adapter protein b-arrestin 2 develop an increased and persistent contact allergic ear swelling in response to the obligate contact sensitizers DNFB and FITC when compared with WT control animals. Histopathological analyses revealed strikingly increased neutrophil infiltration and abundant subcorneal pustules in inflamed ear tissue of DNFB-challenged Arrb2 À / À mice. These observations support a predominant negative regulatory role of b-arrestin 2 for neutrophil recruitment into inflamed skin, consistent with previously reported experimental results in skin wound healing experiments, where increased neutrophil infiltration was observed in Arrb2 À / À when compared with WT mice (Su et al., 2005) . The previously described role for b-arrestin 2 in T lymphocytes during experimentally induced allergic inflammation in lung tissue (Walker et al., 2003) appeared not to be of prominent importance for contact allergic skin inflammation, as evidenced by similar numbers of CD3 þ T cells in inflamed ear tissues of Arrb2 À / À and WT mice and by comparable CHS responses following adoptive transfer of sensitized lymphocytes from Arrb2 À / À or WT mice. The observed differences in the two experimental systems may reflect fundamental differences in tissue-specific control of inflammatory responses.
b-Arrestin 2 deficiency has been shown to result in enhanced CXCL1-dependent neutrophil chemotaxis in the skin air pouch model, indicating enhanced activation of CXCR2 signaling in myeloid immune cells in vivo (Su et al., 2005) . As a potential underlying mechanism, it was reported that b-arrestin 2 is required for the induction and strengthening of integrin-mediated leukocyte adhesion during CXCR2-driven extravasation (Molteni et al., 2009 ). However, our experiments with bone marrow chimeric mice provided evidence that the ability of b-arrestin 2 to attenuate the challenge phase of CHS responses resides predominantly in radioresistant cells and not in radiosensitive immune cells such as neutrophils or macrophages. As a potential explanation for this finding, we discovered that primary cultures of epidermal keratinocytes established from b-arrestin 2-deficient mice produced significantly increased amounts of the proinflammatory chemokines CCL2, CXCL1, and CCL8 in response to TNF-a and IFN-g, two cytokines secreted by allergen-specific T cells. The significantly increased mRNA expression levels of Ccl2, Cxcl1, and Ccl8 in contact allergic ear tissue of Arrb2 À / À mice further supported the notion that the deregulated production of proinflammatory chemokines in b-arrestin 2-deficient keratinocytes may contribute to enhanced neutrophil recruitment and subsequently increased CHS responses. Our experimental findings are consistent with the important role of epidermal keratinocytes in the regulation of skin inflammatory responses that has emerged in recent years (Wittmann and Werfel, 2006; Albanesi, 2010; Gaffal et al., 2013) .
Our studies so far do not directly prove that the deregulated production of proinflammatory chemokines by b-arrestin 2-deficient keratinocytes in vitro represents the key mechanism how CHS responses are increased in Arrb2 À / À mice in vivo. Evidence for a role of b-arrestins in keratinocytes has so far only been reported in the two-stage mouse skin carcinogenesis model (Chun et al., 2009 (Chun et al., , 2010 . It is also conceivable that b-arrestin 2 has an important role in mast cells, which are relatively radioresistant and critically participate in the regulation of contact allergic skin inflammation through the production of proinflammatory mediators. This issue may be resolved in future experiments using mice with cell typespecific conditional deletion of the b-arrestin 2 gene.
As a potential explanation for our finding that b-arrestin 2 regulates the production of proinflammatory chemokines under inflammatory conditions, we speculate that the absence of b-arrestin 2 leads to increased NFkB activity. This assumption is based on several studies demonstrating that b-arrestin 2 inhibits the phosphorylation and degradation of the NFkB inhibitor IkBa. As a result, NFkB is no longer able to translocate into the nucleus and NFkB target genes are downregulated (Gao et al., 2004; Witherow et al., 2004 ). An intriguing possibility is the involvement of anaphylatoxin receptors such as C3aR and C5aR, two GPCRs that have been shown to participate in the regulation of allergic skin inflammation (Tsuji et al., 1997 (Tsuji et al., , 2000 Purwar et al., 2006; Wang et al., 2013) . In mast cells, it was recently shown that b-arrestin 2 inhibits C3a-induced NFkB activation (Gupta et al., 2012) . C3aR is expressed by keratinocytes and contributes to proinflammatory signaling (Purwar et al., 2006) .
In conclusion, we demonstrate in our work that the multifunctional adapter protein b-arrestin 2 has a pivotal role in the regulation of contact allergic skin inflammation. Specifically, b-arrestin 2 profoundly affects epidermal keratinocyte function where its presence is essential to inhibit excessive production of proinflammatory chemokines in response to TNF-a and IFN-g, two cytokines secreted by allergen-specific T cells. We propose that this helps limit the reactive recruitment of Mean levels ( ± SEM) of the indicated chemokines determined by ELISA in supernatants from 10 individual primary keratinocyte cultures generated from newborn Arrb2 À / À and wild-type (WT) control mice that were stimulated with 1,000 U ml À 1 TNF-a, 1,000 U ml À 1 IFN-g, or were left untreated (Ctrl). (c) Mean mRNA expression levels of the indicated genes relative to ubiquitin determined by quantitative real-time reverse-transcriptase-PCR (2 À DCT ± SEM) in contact allergic ear tissue of Arrb2 À / À and WT control mice harvested 48 hours after the second challenge with DNFB (n ¼ 5 per group). *Po0.05; **Po0.01; ***Po0.001. ND, not determined; NS, not significant. myeloid immune cells, most notably neutrophils, and thereby attenuates the allergic inflammatory response.
Our results may be of particular importance for the development of strategies that target candidate GPCRs with ligands that are biased toward selectively affecting G protein-or b arrestin-dependent signaling pathways. This represents an innovative area of current research for the treatment of pain and cardiovascular diseases, which may also be applied for the treatment of inflammatory diseases in the future.
MATERIALS AND METHODS
Mice b-Arrestin 2-deficient (Arrb2 À / À ) C57BL/6 mice were a kind gift from Professor Lefkowitz (Duke University Medical Center, Durham, NC) . Syngeneic (WT) C57BL/6 mice were purchased from Charles River, Sulzfeld, Germany. Animals were bred in our animal facility. All experiments were conducted according to the institutional and national guidelines for the care and use of laboratory animals and were approved by the local government authorities (Landesamt für Natur, Umwelt und Verbraucherschutz North Rhine-Westphalia, Recklinghausen, Germany).
CHS and acute irritative dermatitis
DNFB (Merck, Schwalbach, Germany) was diluted in acetone-olive oil (4:1). Mice were sensitized by painting 50 ml of 0.2% DNFB on the shaved abdomen on days 0 and 1. Controls were treated with 50 ml of acetone-olive oil. For elicitation of CHS, ears of mice were painted with 10 ml of 0.3% DNFB on days 5, 12, and 19. Ear thickness was measured 24, 48, and 96 hours after challenge. Fluorescein isothiocyanate isomer I (FITC, Sigma-Aldrich, Munich, Germany) was diluted 1:1 in acetone:dibutylphtalat. Mice were sensitized by painting 400 ml of 0.5% FITC on the shaved abdomen on days 0, 1, 7, and 8. On day 14, mice were challenged by painting 20 ml of 0.5% FITC on the ear. Control mice were treated with vehicle only. Ear swelling was measured 24 hours after challenge. 12-O-Tetradecanoylphorbol 13-acetate (Sigma-Aldrich) was dissolved in acetone and 3 mg was applied once on one mouse to induce an acute irritative dermatitis. Ear swelling was measured 2, 4, 6, and 24 hours after application. In all models of inflammation, the degree of ear swelling was determined by measuring the difference between the hapten or 12-O-tetradecanoylphorbol 13-acetate-exposed ear and the untreated control ear with a spring-loaded caliper.
Histologic analyses of CHS
Paraffin-embedded ear tissue routinely was stained with hematoxylin and eosin. For immunohistochemistry, primary antibodies for Gr1 (RB6-8C5, BD Pharmingen, Heidelberg, Germany) or CD3 (Serotec MCA1477, 1:500, antigen unmasking: 10 minutes boiling in pH 6 buffer) were used. Slides were incubated with biotinylated rabbit antirat IgG, Streptavidin-AP was added, and color reaction was developed using fast red (Dako, Hamburg, Germany). All histological preparations were analyzed using a Leica DMLB microscope with a connected digital camera.
Flow cytometry
Ear tissue was dissociated mechanically before incubation in 1 mg ml À 1 collagenase D þ 0.02 mg ml À 1 DNAseI (Roche, Mannheim, Germany) in phosphate-buffered saline containing 5% fetal bovine serum (Biochrom, Berlin, Germany) for 30 minutes at 37 1C. Staining was performed with the fluorochrome-conjugated rat anti-mouse antibodies against CD45, CD11b, Ly6G, and Ly6C (BD Biosciences, Heidelberg, Germany) and appropriate isotype controls. Ly6G-and Ly6C-positive cells were analyzed in the CD45 þ / CD11b þ gate. Fluorescence was measured with an FACSCanto flow cytometer system and data were analyzed with the FlowJo software.
Reverse transcriptase-PCR
Tissues were harvested 48 hours after the second challenge and immediately snap-frozen in liquid nitrogen. Total RNA was isolated using the Nucleospin RNA II kit (Macherey-Nagel, Düren, Germany) and was reverse-transcribed using Superscript III (Invitrogen, Darmstadt, Germany). Quantitative PCR was performed using 3 mg of cDNA and Fast SYBR Green Master Mix (ABI, Darmstadt, Germany). Relative gene expression was calculated using the 2 À DCT method. Sequences of primers from 5 0 -3 0 : IL1b 5'-GGGCCTCAA AGGAAAGAATC-3' (forward), 5'-TTCTTTGGGTATTGCTTGGG-3' (reverse), S1008A 5'-GAGTGTCCTCAGTTTGTGCAG-3' (forward), 5'-GCCACACCCACTTTTATCA-3' (reverse), IFN-g 5'-CTCTTCTT GGATATCTGGAGG-3' (forward), 5'-CCTGATTGTCTTTCAAGACT TC-3' (reverse), TNF-a 5'-GATTATGGCTCAGGGTCCAA-3' (forward), 5'-ACAGTCCAGGTCACTGTCCC-3' (reverse), CCL2 5'-CTCA GCCAGATGCAGTTAACG-3' (forward), 5'-GCTGCTGGTGATCCTC TTGT-3' (reverse), CCL8 5'-CTGGGCCAGATAAGGCTCC-3' (forward), 5'-CATGGGGCACTGGATATTGT-3' (reverse), CXCL1 5'-AC CGAAGTCATAGCCACACTCA-3' (forward), 5'-CCGTTACTTGGGG ACACCTT-3' (reverse), CXCL2 5'-CGCTGTCAATGCCTGAAG-3' (forward), 5'-GGCGTCACACTCAAGCTCT-3' (reverse), CXCL10 5'-GCCGTCATTTTCTGCCTCAT-3' (forward), 5'-GCTTCCCTATGGC CCTCATT-3' (reverse), Ubi 5'-AGGCAAGACCATCACCTTGGACG-3' (forward), 5'-CCATCACACCCAAGAACAAGCACA-3' (reverse).
Preparation of bulk spleen and lymph node cells for adoptive transfer experiments
For adoptive lymphocyte transfer experiments, Arrb2 À / À and WT mice were sensitized with DNFB on days 0 and 1. On day 5, cell suspensions were prepared from spleens and draining lymph nodes, depleted of red blood cells, and washed twice in phosphate-buffered saline. Bulk lymphocyte populations were transferred intravenously into naïve WT or Arrb2 À / À C57BL/6 mice (5 Â 10 7 cells per mouse). On days 1 and 7 after transfer, CHS was elicited and ear swelling was measured 48 hours after challenge, as previously described (Gaffal et al., 2013) .
Generation of bone marrow chimeric mice
Bone marrow cells were harvested from femurs and tibias of Arrb2 À / À and WT mice, depleted of red blood cells, and washed twice in phosphate-buffered saline. To generate bone marrow chimeric mice, WT C57BL/6 and Arrb2 À / À mice were whole-body irradiated (9 Gy). On the same day, bone marrow cells were transferred intravenously. (6 Â 10 6 cells per mouse) into irradiated WT or Arrb2 À / À recipients. Six weeks after irradiation, mice were sensitized twice with 0.2% DNFB and CHS was elicited as described.
Primary keratinocyte culture
Primary epidermal keratinocytes were isolated from the skin of newborn mice according to standard procedures (Lichti et al., 
